141 related articles for article (PubMed ID: 36600323)
1. Can I go home now? The safety and efficacy of a new UK paediatric febrile neutropenia protocol for risk-stratified early discharge on oral antibiotics.
Jackson TJ; Napper R; Haeusler GM; Pizer B; Bate J; Grundy RG; Samarasinghe S; Angelini P; Ball-Gamble A; Phillips B; Morgan JE
Arch Dis Child; 2023 Mar; 108(3):192-197. PubMed ID: 36600323
[TBL] [Abstract][Full Text] [Related]
2. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
Loeffen EA; Te Poele EM; Tissing WJ; Boezen HM; de Bont ES
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008382. PubMed ID: 26899263
[TBL] [Abstract][Full Text] [Related]
3. Home-based care of low-risk febrile neutropenia in children-an implementation study in a tertiary paediatric hospital.
Haeusler GM; Gaynor L; Teh B; Babl FE; Orme LM; Segal A; Mechinaud F; Bryant PA; Phillips B; Lourenco RA; Slavin MA; Thursky KA
Support Care Cancer; 2021 Mar; 29(3):1609-1617. PubMed ID: 32740894
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of home-based care of febrile neutropenia in children with cancer.
Tew M; De Abreu Lourenco R; Gordon JR; Thursky KA; Slavin MA; Babl FA; Orme L; Bryant PA; Teh BW; Dalziel K; Haeusler GM
Pediatr Blood Cancer; 2022 Jul; 69(7):e29469. PubMed ID: 34854550
[TBL] [Abstract][Full Text] [Related]
5. Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.
Delebarre M; Gonzales F; Behal H; Tiphaine A; Sudour-Bonnange H; Lutun A; Abbou S; Pertuisel S; Thouvenin-Doulet S; Pellier I; Mansuy L; Piguet C; Paillard C; Blanc L; Thebaud E; Plantaz D; Blouin P; Schneider P; Guillaumat C; Simon P; Domenech C; Pacquement H; Le Meignen M; Pluchart C; Vérite C; Plat G; Martinot A; Duhamel A; Dubos F
Lancet Child Adolesc Health; 2022 Apr; 6(4):260-268. PubMed ID: 34871572
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycoside use in paediatric febrile neutropenia - Outcomes from a nationwide prospective cohort study.
McMullan BJ; Haeusler GM; Hall L; Cooley L; Stewardson AJ; Blyth CC; Jones CA; Konecny P; Babl FE; Mechinaud F; Thursky K;
PLoS One; 2020; 15(9):e0238787. PubMed ID: 32936822
[TBL] [Abstract][Full Text] [Related]
7. Quest for certainty regarding early discharge in paediatric low-risk febrile neutropenia: a multicentre qualitative focus group discussion study involving patients, parents and healthcare professionals in the UK.
Morgan JE; Phillips B; Stewart LA; Atkin K
BMJ Open; 2018 May; 8(5):e020324. PubMed ID: 29764879
[TBL] [Abstract][Full Text] [Related]
8. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
9. Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study.
Miedema KG; Tissing WJ; Abbink FC; Ball LM; Michiels EM; van Vliet MJ; de Vries WY; Kamps WA; Norbruis OF; Fiocco M; de Groot-Kruseman HA; van de Wetering MD; de Bont ES
Eur J Cancer; 2016 Jan; 53():16-24. PubMed ID: 26700076
[TBL] [Abstract][Full Text] [Related]
10. Assessing Safe Discharge Criteria for Pediatric Oncology Patients Admitted for Febrile Neutropenia.
Huschart E; Ducore J; Chung J
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e880-e885. PubMed ID: 33625079
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of step-down to oral outpatient treatment versus inpatient antimicrobial treatment in pediatric cancer patients with febrile neutropenia: A noninferiority multicenter randomized clinical trial.
Avilés-Robles MJ; Reyes-López A; Otero-Mendoza FJ; Valencia-Garin AU; Peñaloza-González JG; Rosales-Uribe RE; Muñoz-Hernández O; Garduño-Espinosa J; Juárez-Villegas L; Zapata-Tarrés M
Pediatr Blood Cancer; 2020 Jun; 67(6):e28251. PubMed ID: 32196898
[TBL] [Abstract][Full Text] [Related]
12. Early Discharge of Neutropenic Pediatric Oncology Patients Admitted With Fever.
Villanueva MA; August KJ
Pediatr Blood Cancer; 2016 Oct; 63(10):1829-33. PubMed ID: 27196265
[TBL] [Abstract][Full Text] [Related]
13. Safety of reducing antibiotic use in children with febrile neutropenia: A systematic review.
Moortgat J; Boulanger C; Chatzis O
Pediatr Hematol Oncol; 2022 Nov; 39(8):707-723. PubMed ID: 35465847
[TBL] [Abstract][Full Text] [Related]
14. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.
Rivas-Ruiz R; Villasis-Keever M; Miranda-Novales G; Castelán-Martínez OD; Rivas-Contreras S
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009031. PubMed ID: 30887505
[TBL] [Abstract][Full Text] [Related]
15. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.
Bash RO; Katz JA; Cash JV; Buchanan GR
Cancer; 1994 Jul; 74(1):189-96. PubMed ID: 8004575
[TBL] [Abstract][Full Text] [Related]
16. Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting.
Dommett R; Geary J; Freeman S; Hartley J; Sharland M; Davidson A; Tulloh R; Taj M; Stoneham S; Chisholm JC
Eur J Cancer; 2009 Nov; 45(16):2843-9. PubMed ID: 19616427
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia.
Janssens KP; Valete COS; Silva ARAD; Ferman SE
J Pediatr (Rio J); 2021; 97(3):302-308. PubMed ID: 32505617
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Children Discharged Prior to Absolute Neutrophil Count Recovery After Admission for Febrile Neutropenia.
Peters S; Adler M; Rossoff J
J Pediatr Hematol Oncol; 2023 Nov; 45(8):e948-e952. PubMed ID: 37700440
[TBL] [Abstract][Full Text] [Related]
19. Meta-ethnography of experiences of early discharge, with a focus on paediatric febrile neutropenia.
Morgan JE; Cleminson J; Stewart LA; Phillips RS; Atkin K
Support Care Cancer; 2018 Apr; 26(4):1039-1050. PubMed ID: 29285558
[TBL] [Abstract][Full Text] [Related]
20. Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study.
Innes HE; Smith DB; O'Reilly SM; Clark PI; Kelly V; Marshall E
Br J Cancer; 2003 Jul; 89(1):43-9. PubMed ID: 12838298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
